MELBOURNE, Australia, April 27, 2026 — Nutromics, an Australian founded startup developing a wearable molecular sensing platform, today announced it has secured AU$3 million in non-dilutive funding through the Australian Government’s Cooperative Research Centres (CRC) Projects Round 18, as part of a total project value of AU$11.2 million. The funding will support the development of a world-first sepsis management microneedle patch capable of real-time, multi-analyte sensing with sensor design accelerated by cutting-edge robotics.
Sepsis is a leading cause of death globally, with 11 million sepsis-related deaths in 2020, according to the World Health Organization (WHO). A national analysis from the Australian Commission on Safety and Quality in Health Care found that it affects around 84,000 people each year in Australia alone, of which 12,000 will die. Every hour of delayed treatment increases sepsis mortality risk by 8%, despite advances in modern medicine.
Running from July 1, 2026 to June 30, 2029, this project brings together a consortium of industry and academic partners including Bosch Australia Manufacturing Solutions (BAMS), Global Life Sciences Solutions Australia Pty Ltd T/as Cytiva, The University of Sydney, The University of New South Wales, Tecan Australia, and A.T.A Scientific. The consortium will develop a wearable patch that gives clinicians the ability to identify and monitor sepsis in real time, enabling earlier intervention and saving lives. The patch will be validated in a clinical study across ICU and emergency settings, building Australia’s sovereign diagnostic capability.